Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · IEX Real-Time Price · USD
25.44
+2.18 (9.37%)
At close: Jul 1, 2024, 4:00 PM
26.50
+1.06 (4.17%)
Pre-market: Jul 2, 2024, 8:00 AM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $899.98 million as of July 2, 2024.
Market Cap
899.98M
Enterprise Value
708.61M
1-Year Change
n/a
Ranking
Category
Stock Price
$25.44
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $899.98M, an increase of 49.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 900.00M | 49.65% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simulations Plus | 922.90M |
| Maravai LifeSciences Holdings | 921.85M |
| Liquidia | 920.02M |
| Tyra Biosciences | 906.76M |
| Avanos Medical | 905.22M |
| Centessa Pharmaceuticals | 884.24M |
| Cronos Group | 878.63M |
| Silence Therapeutics | 872.83M |